2021. Study of 18β glycyrrhetinic acid for the prevention of progression of diabetes induced neuropathy in laboratory animals. International Journal of Pharmaceutical Sciences and Drug Research. 13, 2 (Mar. 2021), 107–119. DOI:https://doi.org/10.25004/IJPSDR.2021.130201.